Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Pfizer COVID-19 vaccine-induced peritonitis

Amani Elimam and Sarah Al-Dhahir
Download PDF
DOI: https://doi.org/10.7861/clinmed.22-4-s53
Clin Med July 2022
Amani Elimam
AHabib Medical Group, Riyadh, Saudi Arabia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Al-Dhahir
BKings College University, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Introduction

The COVID-19 vaccine was one of the essential methods for controlling the pandemic and there was a significant decrease in mortality and morbidity after vaccine initiation.1

The safety of vaccines was assessed on large groups of participants and the adverse effects were frequently reported and published.2

We report the first case of peritonitis that was diagnosed 2 days after first dose of Pfizer BioNTech COVID-19 mRNA vaccine and that recurred after second and third dose of vaccine.

Case presentation

A 62-year-old man, with no past medical history apart from hyperlipidaemia treated with statins, presented 2 days after he received the first dose of Pfizer BioNTech COVID-19 mRNA vaccine with diffused abdominal pain associated with nausea. Clinical examination showed generalised abdominal tenderness more severe in the left iliac fossa. Blood testes showed C-reactive protein (CRP) of 150 mg/L and an erythrocyte sedimentation rate of 39. Computed tomography of the abdomen confirmed evidence of diffused peritonitis with appendicitis and few diverticula laterally near the iliac region with thickening of its wall with surrounding edematous changes and fat stranding.

The first peritonitis required hospitalisation and intravenous antibiotic (piperacillin/tazobactam and metronidazole). Significant improvement of abdominal pain and decreased inflammatory markers were seen within a few days.

With the second and third dose of Pfizer BioNTech COVID-19 mRNA vaccine, the patient again experienced symptoms of abdominal pain 2 days after the vaccine, but the pain was less severe and the patient required no hospitalisation, although inflammatory markers were high. He received an oral antibiotic (metronidazole and ciprofloxacin), with good response.

Discussion

The patient was diagnosed with peritonitis on the basis of clinical, laboratory and radiological findings after the first, second, and third doses of Pfizer BioNTech COVID-19 mRNA vaccine.

The mechanism responsible for vaccine-induced peritonitis is unclear.

There are some data and case reports about COVID-19-infection-induced colitis and peritonitis, but no data related to vaccine induced peritonitis.3

Conclusion

To our knowledge, this is the first report of peritonitis post-COVID-19 vaccine. It is important to report a rare COVID-19 vaccine side effect and the manifestation of the disease to prevent serious complications by early diagnosis and management.

  • © Royal College of Physicians 2022. All rights reserved.

References

  1. ↵
    1. Centers for Disease Control and Prevention
    . COVID-19 Vaccination and non-COVID-19 mortality risk — seven integrated health care organizations, United States, December 14, 2020–July 31, 2021. CDC, 2021. www.cdc.gov/mmwr/volumes/70/wr/mm7043e2.htm [Accessed 16 March 2022].
  2. ↵
    1. Europena Medicines Agency
    . Comirnaty summary of product characteristics. www.ema.europa.eu/documents/product-information/comirnaty-epar-product-information_en.pdf [Aaccessed 25 March 2021].
  3. ↵
    1. Asil RS
    , Mahmoodi S, Zamani A, Hakakzadeh A, Jamalid E. Abdominal pain and diffuse colitis following COVID-19 infection: report of a case. Int J Surg Case Rep 2021;88:106473.
    OpenUrl
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Pfizer COVID-19 vaccine-induced peritonitis
Amani Elimam, Sarah Al-Dhahir
Clinical Medicine Jul 2022, 22 (Suppl 4) 53; DOI: 10.7861/clinmed.22-4-s53

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Pfizer COVID-19 vaccine-induced peritonitis
Amani Elimam, Sarah Al-Dhahir
Clinical Medicine Jul 2022, 22 (Suppl 4) 53; DOI: 10.7861/clinmed.22-4-s53
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Introduction
    • Case presentation
    • Discussion
    • Conclusion
    • References
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The Macklin effect in COVID-19
  • Acute management of suspected vaccine induced thrombocytopenia and thrombosis
  • Pneumothorax and pneumomediastinum in COVID-19
Show more COVID-19

Similar Articles

FAQs

  • Difficulty logging in.

There is currently no login required to access the journals. Please go to the home page and simply click on the edition that you wish to read. If you are still unable to access the content you require, please let us know through the 'Contact us' page.

  • Can't find the CME questionnaire.

The read-only self-assessment questionnaire (SAQ) can be found after the CME section in each edition of Clinical Medicine. RCP members and fellows (using their login details for the main RCP website) are able to access the full SAQ with answers and are awarded 2 CPD points upon successful (8/10) completion from:  https://cme.rcplondon.ac.uk

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians